| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 434.94B | 425.16B | 394.13B | 372.15B | 340.29B | 352.15B |
| Gross Profit | 65.31B | 62.80B | 43.31B | 42.04B | 46.86B | 48.16B |
| EBITDA | 41.30B | 38.75B | 21.09B | 21.95B | 29.01B | 29.44B |
| Net Income | 27.33B | 26.44B | 13.88B | 15.19B | 17.67B | 17.19B |
Balance Sheet | ||||||
| Total Assets | 350.97B | 378.69B | 334.14B | 318.01B | 295.33B | 339.39B |
| Cash, Cash Equivalents and Short-Term Investments | 61.86B | 57.29B | 50.21B | 75.60B | 66.08B | 129.32B |
| Total Debt | 32.97B | 28.09B | 23.84B | 24.52B | 25.31B | 25.35B |
| Total Liabilities | 179.84B | 206.50B | 179.67B | 176.68B | 153.65B | 192.71B |
| Stockholders Equity | 170.19B | 171.21B | 153.57B | 140.49B | 140.92B | 145.92B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 7.05B | -18.19B | 29.27B | -38.64B | 26.22B |
| Operating Cash Flow | 0.00 | 11.18B | -11.12B | 32.27B | -36.09B | 29.15B |
| Investing Cash Flow | 0.00 | 1.60B | -6.09B | -4.74B | -4.55B | -3.95B |
| Financing Cash Flow | 0.00 | -5.75B | -9.05B | -18.43B | -22.57B | -12.66B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥346.74B | 11.11 | 16.55% | 4.26% | 9.49% | 64.79% | |
75 Outperform | ¥2.69T | 10.54 | 14.23% | 2.47% | 2.27% | 70.36% | |
75 Outperform | ¥1.99T | 12.97 | 11.22% | 1.48% | 5.14% | 773.86% | |
74 Outperform | ¥283.79B | 9.47 | 7.62% | 3.44% | 7.54% | 115.47% | |
71 Outperform | ¥2.98T | 15.14 | 13.56% | 1.96% | 10.52% | 71.09% | |
67 Neutral | ¥2.71T | 15.64 | 16.64% | 1.83% | 6.60% | 114.38% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |